Healthcare -
Biotechnology - NASDAQ - US
$ 2.3
-4.96 %
$ 75 M
Market Cap
-0.77
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
20.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
PepGen Inc.
PEPG has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PEPG
EBIT FORECAST
EBIT Forecast Chart PEPG
NET INCOME FORECAST
Net Income Chart PEPG